-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

57th ASH Annual Meeting and Exposition (December 5-8, 2015)

Thursday, December 3, 2015

3:00 PM-7:00 PM


Registration  
Events

Friday, December 4, 2015

7:00 AM-6:00 PM


Registration  
Events

12:00 PM-5:00 PM


Trainee Day  
Trainee Activities and Services

12:30 PM-5:00 PM

Training Program Directors Workshop


Training Program Directors' Workshop  
Special-Interest Sessions

1:00 PM-6:00 PM

2:00 PM-5:00 PM

5:00 PM-7:00 PM


Trainee Welcome Reception  
Trainee Activities and Services

Saturday, December 5, 2015

7:00 AM-6:00 PM


Registration  
Events

7:30 AM-9:00 AM

Disorders of Platelet Number or Function

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Health Services and Outcomes Research – Non-Malignant Conditions


Targeting the Epigenome  
Special Scientific Symposia


Update in Large Cell Lymphoma  
Education Program

9:00 AM-9:30 AM

9:00 AM-7:30 PM

9:30 AM-11:00 AM

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Clinical Allogeneic Transplantation: Results


Aging and Thrombosis  
Scientific Program


Checkpoint, Please?  
Scientific Program


New Insights in Hemolytic Anemia  
Education Program


Telomeres and Bone Marrow Failure  
Scientific Program

11:00 AM-12:30 PM

11:00 AM-5:00 PM


Exhibits Open  
Events

11:15 AM-12:15 PM


Apoptosis  
Meet the Scientist


Career Development Lunch- Room 1  
Trainee Activities and Services


Career Development Lunch- Room 2  
Trainee Activities and Services


Children with Histiocytic Disorders  
How I Treat: Bringing Science to Clinical Dilemmas


Continuing Conversations with the Speakers on Checkpoint Please?  
Continuing Conversations with the Speakers


Cord Blood Expansion  
Meet the Scientist


Determining Length of Anticoagulation  
How I Treat: Bringing Science to Clinical Dilemmas


Double Hit Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Epigenetics  
Meet the Scientist


Grassroots Network Lunch  
Special-Interest Sessions


Hemostasis  
Meet the Scientist


Myelofibrosis  
How I Treat: Bringing Science to Clinical Dilemmas


Patients with Acute Myeloid Leukemia Unfit for Intensive Therapy  
How I Treat: Bringing Science to Clinical Dilemmas


Pediatric Myeloid Neoplasms  
Meet the Scientist


Sickle Cell Gene Therapy  
Meet the Scientist


Transfusion Challenges in Sickle Cell Disease  
How I Treat: Bringing Science to Clinical Dilemmas


Young Patients with Chronic Lymphocytic Leukemia  
How I Treat: Bringing Science to Clinical Dilemmas

11:30 AM-12:30 PM

12:00 PM-1:30 PM

Hemoglobinopathies, Excluding Thalassemia – Clinical

Disorders of Platelet Number or Function

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Myelodysplastic Syndromes – Clinical Studies

Adoptive Immunotherapy

12:30 PM-1:30 PM


Ham-Wasserman Lecture  
General Sessions

1:30 PM-2:00 PM

2:00 PM-3:30 PM

Disorders of Platelet Number or Function

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy


Aging and Thrombosis  
Scientific Program


Contemporary Therapy of Lymphoma  
Education Program


Cytosis: Too Much of a Good Thing  
Education Program


Hematopoiesis and the Niche  
Scientific Program


Precision Medicine in Cancer Therapy: N-of-1  
Special Scientific Symposia


Special Symposium on Quality  
Special-Interest Sessions

3:30 PM-4:00 PM

4:00 PM-5:30 PM

Blood Coagulation and Fibrinolytic Factors

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myelodysplastic Syndromes – Basic and Translational Studies

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Clinical Allogeneic Transplantation: Results


Checkpoint, Please?  
Scientific Program


Multiple Advances in Myeloma  
Education Program


Update in Large Cell Lymphoma  
Education Program

5:30 PM-7:30 PM


Poster Session I - Presentations  
Oral and Poster Abstracts

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism


102. Regulation of Iron Metabolism: Poster I  
Oral and Poster Abstracts

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia – Clinical

Granulocytes, Monocytes and Macrophages

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Platelet Activation and Biochemistry

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis: Poster I  
Oral and Poster Abstracts

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster I  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster I  
Oral and Poster Abstracts

Chromosomal Rearrangements and DNA Repair

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Basic and Translational Studies

Myelodysplastic Syndromes – Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Malignant Stem and Progenitor Cells

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster I  
Oral and Poster Abstracts

Cell Collection and Processing


711. Cell Collection and Processing: Poster I  
Oral and Poster Abstracts

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster I  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

6:30 PM-9:00 PM

Sunday, December 6, 2015

7:00 AM-9:00 AM


Hematology Course Directors' Workshop  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

7:30 AM-9:00 AM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Chromosomal Rearrangements and DNA Repair

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


Cytosis: Too Much of a Good Thing  
Education Program


Hematopoiesis and the Niche  
Scientific Program


Multiple Advances in Myeloma  
Education Program


New Insights in Hemolytic Anemia  
Education Program


Telomeres and Bone Marrow Failure  
Scientific Program

9:00 AM-9:30 AM

9:00 AM-8:00 PM

9:30 AM-11:00 AM

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Blood Coagulation and Fibrinolytic Factors

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis


Challenges in Hemophilia Care  
Education Program


Contemporary Therapy of Lymphoma  
Education Program

9:30 AM-11:15 AM

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

10:00 AM-5:00 PM


Exhibits Open  
Events

11:00 AM-12:30 PM

11:15 AM-12:15 PM


Aplastic Anemia  
Meet the Scientist


Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia  
How I Treat: Bringing Science to Clinical Dilemmas


Choosing Between Oral Anticoagulants  
How I Treat: Bringing Science to Clinical Dilemmas


Featured Topic: Gene Therapy  
Special-Interest Sessions


Genomics of Myeloma  
Meet the Scientist


Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia  
How I Treat: Bringing Science to Clinical Dilemmas


Hemophilia Inhibitor Prevention and Management  
How I Treat: Bringing Science to Clinical Dilemmas


iPSC Models of Hemoglobinopathies  
Meet the Scientist


Linking Therapy with Genomics  
Meet the Scientist


Lower-Risk Myelodysplastic Syndromes  
How I Treat: Bringing Science to Clinical Dilemmas


Meet the Blood Editors  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions


Newly Diagnosed Patients with Multiple Myeloma  
How I Treat: Bringing Science to Clinical Dilemmas


Optimizing Diagnostic Approaches for von Willebrand Disease  
How I Treat: Bringing Science to Clinical Dilemmas


Patients with Chronic Myeloid Leukemia Who Want to Become Pregnant  
How I Treat: Bringing Science to Clinical Dilemmas


Precision Medicine  
Meet the Scientist


Social Media for the Hematologist  
Special-Interest Sessions


Tissue Factor  
Meet the Scientist

Trainee Simultaneous Didactic Session


Trainee Simultaneous Didactic Session  
Trainee Activities and Services

Trainee Simultaneous Didactic Session


Trainee Simultaneous Didactic Session  
Trainee Activities and Services

11:15 AM-12:30 PM

11:30 AM-12:30 PM

12:00 PM-1:30 PM

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Hematopoietic Stem and Progenitor Biology

Acute Lymphoblastic Leukemia: Clinical Studies

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Gene Therapy and Transfer

Health Services and Outcomes Research – Malignant Diseases

12:30 PM-1:30 PM


ASH/EHA Joint Symposium  
General Sessions

1:30 PM-2:00 PM

2:00 PM-4:00 PM

Plenary


Plenary Scientific Session  
General Sessions

4:00 PM-4:30 PM

4:30 PM-5:45 PM


The Epic Story of Blood  
Special-Interest Sessions

4:30 PM-6:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Disorders of Coagulation or Fibrinolysis

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myelodysplastic Syndromes – Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Cell Collection and Processing


711. Cell Collection and Processing I  
Oral and Poster Abstracts

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

6:00 PM-8:00 PM


Poster Session II - Presentations  
Oral and Poster Abstracts

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism


102. Regulation of Iron Metabolism: Poster II  
Oral and Poster Abstracts

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia – Clinical

Granulocytes, Monocytes and Macrophages

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Platelet Activation and Biochemistry

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis: Poster II  
Oral and Poster Abstracts

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster II  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster II  
Oral and Poster Abstracts

Chromosomal Rearrangements and DNA Repair

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Basic and Translational Studies

Myelodysplastic Syndromes – Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Malignant Stem and Progenitor Cells

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster II  
Oral and Poster Abstracts

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster II  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

7:00 PM-8:00 PM

Monday, December 7, 2015

7:00 AM-8:30 AM

Regulation of Iron Metabolism

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Platelet Activation and Biochemistry

Blood Coagulation and Fibrinolytic Factors

Antithrombotic Therapy

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Cell Collection and Processing

Clinical Autologous Transplantation: Results

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

7:00 AM-11:30 AM


Consultative Hematology Course  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

9:00 AM-10:00 AM

10:00 AM-10:30 AM

10:00 AM-2:00 PM


Exhibits Open  
Events

10:00 AM-8:00 PM

10:30 AM-12:00 PM

Regulation of Iron Metabolism

Hemoglobinopathies, Excluding Thalassemia – Clinical

Disorders of Coagulation or Fibrinolysis

Oncogenes and Tumor Suppressors

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases


Challenges in Hemophilia Care  
Education Program


Infections and the Blood Supply  
Spotlight Sessions

12:00 PM-1:30 PM

12:15 PM-1:15 PM


Featured Topic: Precision Therapy  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions

Trainee Simultaneous Didactic Session


Trainee Simultaneous Didactic Session  
Trainee Activities and Services

Trainee Simultaneous Didactic Session


Trainee Simultaneous Didactic Session  
Trainee Activities and Services

1:30 PM-2:30 PM

2:30 PM-2:45 PM

2:45 PM-4:15 PM

Thalassemia and Globin Gene Regulation

Granulocytes, Monocytes and Macrophages

Pathophysiology of Thrombosis

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Myelodysplastic Syndromes – Basic and Translational Studies

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Health Services and Outcomes Research – Non-Malignant Conditions

4:30 PM-6:00 PM

Thalassemia and Globin Gene Regulation

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Myeloproliferative Syndromes: Clinical

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Malignant Stem and Progenitor Cells

Adoptive Immunotherapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Malignant Diseases

Health Services and Outcomes Research – Malignant Diseases

4:30 PM-6:30 PM

6:00 PM-8:00 PM


Poster Session III - Presentations  
Oral and Poster Abstracts

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia – Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia – Clinical

Lymphocytes, Lymphocyte Activation and Immunodeficiency, including HIV and Other Infections

Platelet Activation and Biochemistry

Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Epigenetic, Transcriptional and Translational Control

Hematopoiesis: Cytokines, Signal Transduction, Apoptosis and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster III  
Oral and Poster Abstracts

Chromosomal Rearrangements and DNA Repair

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance – Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Hodgkin Lymphoma: Biology, excluding Therapy

Non-Hodgkin Lymphoma: Biology, excluding Therapy

Lymphoma: Chemotherapy, excluding Pre-Clinical Models

Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models

Lymphoma: Pre-Clinical – Chemotherapy and Biologic Agents

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes – Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation:

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Malignant Stem and Progenitor Cells

Experimental Transplantation: Basic Biology, Engraftment and Disease Activity

Experimental Transplantation: Immune Function, GVHD and Graft-versus-Tumor Effects

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster III  
Oral and Poster Abstracts

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Transplant Toxicities

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster III  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services and Outcomes Research – Non-Malignant Conditions

Health Services and Outcomes Research – Malignant Diseases

6:15 PM-7:45 PM

Granulocytes, Monocytes and Macrophages

Antithrombotic Therapy


332. Antithrombotic Therapy II  
Oral and Poster Abstracts

Hematopoietic Stem and Progenitor Biology

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

Myelodysplastic Syndromes – Clinical Studies

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Autologous Transplantation: Results

7:30 PM-9:00 PM

Tuesday, December 8, 2015

7:00 AM-1:30 PM


Registration  
Events

7:30 AM-9:00 AM


Late-Breaking Abstracts Session  
General Sessions

9:30 AM-9:45 AM

9:45 AM-11:15 AM


Presidential Symposium  
General Sessions

11:15 AM-11:30 AM


Business Meeting  
General Sessions

11:30 AM-1:00 PM


Best of ASH  
General Sessions